Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DocGo (DCGO) Share-based Compensation: 2020-2024

Historic Share-based Compensation for DocGo (DCGO) over the last 5 years, with FY2024 value amounting to $13.6 million.

  • DocGo's Share-based Compensation rose 4736.61% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.1 million, marking a year-over-year increase of 3923.69%. This contributed to the annual value of $13.6 million for FY2024, which is 3498.03% down from last year.
  • As of FY2024, DocGo's Share-based Compensation stood at $13.6 million, which was down 3498.03% from $21.0 million recorded in FY2023.
  • DocGo's 5-year Share-based Compensation high stood at $21.0 million for FY2023, and its period low was $687072.0 during FY2020.
  • Over the past 5 years, DocGo's median Share-based Compensation value was $8.1 million (recorded in 2022), while the average stood at $8.9 million.
  • As far as peak fluctuations go, DocGo's Share-based Compensation skyrocketed by 48521.11% in 2022, and later tumbled by 3498.03% in 2024.
  • DocGo's Share-based Compensation (Annual) stood at $687072.0 in 2020, then surged by 100.32% to $1.4 million in 2021, then soared by 485.21% to $8.1 million in 2022, then soared by 160.34% to $21.0 million in 2023, then plummeted by 34.98% to $13.6 million in 2024.
  • Its Share-based Compensation stands at $13.6 million for FY2024, versus $21.0 million for FY2023 and $8.1 million for FY2022.